首页> 美国卫生研究院文献>other >5-HT2A receptor blockade and 5-HT2C receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen
【2h】

5-HT2A receptor blockade and 5-HT2C receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen

机译:5-HT2A受体阻滞和5-HT2C受体激活相互作用以减少Cocaine HyperCOCONION和FOS蛋白表达在凯特 - 腐败中

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Both the 5-HT2A receptor (R) antagonist M100907 and the 5-HT2CR agonist MK212 attenuate cocaine-induced dopamine release and hyperlocomotion. This study examined whether these drugs interact to reduce cocaine hyperlocomotion and Fos expression in the striatum and prefrontal cortex. We first determined from dose-effect functions a low dose of both M100907 and MK212 that failed to alter cocaine (15 mg/kg, i.p.) hyperlocomotion. Subsequently we examined whether these subthreshold doses given together would attenuate cocaine hyperlocomotion, consistent with a 5-HT2A/5-HT2CR interaction. Separate groups of rats received two sequential drug injections 5 min apart immediately before a 1-h locomotion test as follows: 1) saline + saline, 2) saline + cocaine, 3) 0.025 mg/kg M100907 + cocaine, 4) 0.125 mg/kg MK212 + cocaine, or 5) cocktail combination of 0.025 mg/kg M100907 and 0.125 mg/kg MK212 + cocaine. Brains were extracted for Fos immunohistochemistry 90 min after the second injection. We next examined the effects of 0.025 mg/kg M100907 and 0.125 mg/kg MK212, alone and in combination, on spontaneous locomotor activity. While neither drug given alone produced any effects, the M100907/MK212 cocktail attenuated cocaine hyperlocomotion as well as cocaine-induced Fos expression in the dorsolateral caudate-putamen (CPu), but had no effect on spontaneous locomotion. The findings suggest that 5-HT2ARs and 5-HT2CRs interact to attenuate cocaine hyperlocomotion and Fos expression in the CPu, and that the CPu is a potential locus of the interactive effects between these 5-HT2R subtypes on behavior. Further research investigating combined 5-HT2AR antagonism and 5-HT2CR agonism as a treatment for cocaine dependence is warranted.
机译:5-HT2A受体拮抗剂M100907和5-HT2CR激动剂MK212均可减弱可卡因诱导的多巴胺释放和运动过度。这项研究检查了这些药物是否相互作用,以减少纹状体和前额叶皮层中的可卡因运动过度和Fos表达。我们首先从剂量效应功能中确定了低剂量的M100907和MK212,它们都不能改变可卡因(15 mg / kg,i.p.)的过度运动。随后,我们检查了一起使用这些亚阈值剂量是否会减弱可卡因的超运动,这与5-HT2A / 5-HT2CR相互作用相一致。单独的大鼠组在进行1小时运动测试之前立即相隔5分钟进行两次连续药物注射,如下所示:1)生理盐水+生理盐水,2)生理盐水+可卡因,3)0.025 mg / kg M100907 +可卡因,4)0.125 mg / kg kg MK212 +可卡因,或5)0.025 mg / kg M100907和0.125 mg / kg MK212 +可卡因的混合物。第二次注射后90分钟提取大脑进行Fos免疫组化。接下来,我们检查了0.025 mg / kg M100907和0.125 mg / kg MK212单独或组合对自发运动活性的影响。虽然两种药物都不单独产生任何作用,但M100907 / MK212鸡尾酒减弱了可卡因的过度运动以及可卡因诱导的Fos在背侧尾状丘脑(CPu)中的表达,但对自发运动没有影响。研究结果表明5-HT2ARs和5-HT2CRs相互作用以减弱可卡因超运动和Fos表达在CPu中,并且CPu是这些5-HT2R亚型之间行为相互作用的潜在作用源。值得进一步研究,研究联合5-HT2AR拮抗作用和5-HT2CR激动作为可卡因依赖的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号